Key highlights from Dr. Reddy's Laboratories (DRREDDY) Q4 FY23 Earnings Concall Q&A Highlights: [00:21:55] Mikhaila at Barclays asked more details about the
Dr. Reddy’s Laboratories Q4 FY23 Earnings Conference Call Insights
Categories
pharmaceuticals
Aarti Industries Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q4 FY23 Earnings Concall Management Update: [00:08:20] AARTIIND said its EBITDA growth guidance for FY24
Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore
Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth
Sanofi Ltd Q4FY23 results out, revenue soars by 4%
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Company has three brands (Lantus, Allegra, Combiflam) in top
Earnings Summary Of Dr Reddy ‘s Laboratories Limited For Q4 FY23
Dr. Reddy's Laboratories Limited is an Indian multinational pharmaceutical company with a presence in over 25 countries. It was founded in 1984
Alembic Pharmaceuticals Limited (APLLTD) Q4 FY23 Earnings Concall Transcript
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Raj Kumar Baheti -- Director, Finance & Chief Financial Officer
Tatva Chintan Pharma Chem Limited (TATVA) Q4 FY23 Earnings Concall Transcript
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Dinesh Sodani -- GM Finance Chintan Shah -- Managing Director
Ajanta Pharma Limited (AJANTPHARM) Q4 FY23 Earnings Concall Transcript
Ajanta Pharma Limited (NSE:AJANTPHARM) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Yogesh Agrawal -- Managing Director Rajesh Agrawal -- Joint Managing Director Arvind
Earnings | ALEMBIC PHARMACEUTICALS LIMITED (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1.3% YoY.
Alembic Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical products,
Earnings | Ajanta Pharma Ltd. (NSE: AJANTAPHARMA): Q4FY23 Results Out; Total Income rises 2.1% YoY.
Ajanta Pharma is a leading Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of high-quality specialty pharmaceutical finished dosages.
Earnings | Aarti Drugs Ltd. (NSE: AARTIDRUGS): Q4FY23 Results Out; Total Income rise 8.5% YoY
Aarti Drugs Ltd. is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs), intermediates,
Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights
https://youtu.be/5Vtl-XMN8qg Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding non-ARV formulation
Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Transcript
Laurus Labs Limited (NSE:LAURUSLABS) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Satyanarayana Chava -- Founder & Chief Executive Officer V V
Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!
Stock Data: TickerNSE: BROOKS & BSE: 533543ExchangeNSE & BSEIndustryPHARMACEUTICALS & BIOTECHNOLOGY Price Performance: Last 5 Days-1.49%YTD-39.27%Last 12 Months-33.95% Company Description: Brooks Laboratories Ltd
Dr. Reddy’s Laboratories: One Of The Major Player In Generic Segment
“We are progressing well on our pipeline products. The number of filings in several of our key markets have been improving. The
Neuland Laboratories Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices are becoming
Sequent Scientific Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Management Update: [00:05:37] SEQUENT said that in the API business, the
Supriya Lifescience Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Management Update: [00:04:00] SUPRIYA said its primary focus remains on expanding
Orchid Pharma Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Q&A Highlights: [00:04:43] Himanshu Upadhyay from o3 Capital asked what changed
Earnings Summary Of Lupin Limited For Q3 FY23
Lupin Limited is a pharmaceutical company headquartered in Mumbai, India. The company was founded in 1968 and has operations in over 100
Earnings Summary Of Jubilant Pharmova Limited For Q3 FY23
Jubilant Pharmova Limited (NSE: JUBLPHARMA) was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in